Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous muscle-derived cells for gastrointestinal repair

A preparation of autologous human muscle-derived stem cells (MDSCs), that can potentially be used for engraftment purposes for gastrointestinal (GI) repair (GIR). Upon administration, autologous muscle-derived cells (AMDC) for GI repair (AMDC-GIR) differentiate and self-renew. This allows for certain damaged GI tissues to be repaired.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	AMDC-GIR AMDCs for GIR autologous muscle-derived stem cells for GIR

autologous muscle-derived cells for gastrointestinal repair

Search NCI's Drug Dictionary